{"name":"Immorna Biotherapeutics, Inc.","slug":"immorna-biotherapeutics-inc","ticker":"","exchange":"","domain":"immornabiotherapeutics.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxQcWJPM1VBVUtZMklibGJ0UXMxZmJUU2EtTXF5c3BqV2NNTlF2VTY3aEcwTG9INi00QUJHaTlTbUNZTU1Fd0FubjFzTXk5VnpFYjF3QXZkZWw5a0xGdUZUNXZnYjdDb0hRZlphbE1sbXBENTF5S2tkQVBLUFc2M3c3R3FUY1BQWnlSUi03N1R5cmtaOEpMd0hFRUo3UmhCeG56YVdWZDR2VXdEN29ZeWw1SERRMjYtZV8xM3hvUjBCTzZCbkZ3UkJhUVp5ZDVmYnlWbnVzTUlkLWh0cmtGVHU1VlJLY1h0WWVXcUpTc0RpcDR3OTZNbm53blpfQm9Nems?oc=5","date":"2026-04-07","type":"pipeline","source":"Barchart.com","summary":"Herpes Zoster Treatment Market Size in the 7MM is projected to increase at a significantly CAGR by 2036, estimates DelveInsight - Barchart.com","headline":"Herpes Zoster Treatment Market Size in the 7MM is projected to increase at a significantly CAGR by 2036, estimates Delve","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwJBVV95cUxNdEhFMFY5N252aFR6MG1vbG9qQW56TlBsTkI0Q2FsWVowa2pkTVNIY0hYbXlSWGdKZGVHbmF2MWhncUdFUjROUHF4REE0TjUtSTVWVzlVS01VWjRDYW96RVFwX19EVk1mRlhSdk9hVXVMWV80YzRaekpuTDBXVDVkTjE2V1VzZFRvVHF5OEdmSUoyaktSM2Via1pGbW9YTjh1b2pxd3kxc2tlS2FaN1E2bHpxSnloaUdZWjRjckZ1VDlMWFg3dnp0eG9YUEt5REtoN0JPdVh2ZkZkaXdfbjVBNEdndFBzZ1c2TUJIMU1FNUlvUkd3UFB6ODcxX2NIMUxiQm9PaXB1Umtic0c0MHJVeW8ydFFhYlN4dWNKLUtNVTZtTi1mam5ZeDBYbVZqbUYxUVZieVlueU9GNzg?oc=5","date":"2026-03-09","type":"pipeline","source":"GlobeNewswire","summary":"Herpes Zoster Market Poised for Robust Growth During the - GlobeNewswire","headline":"Herpes Zoster Market Poised for Robust Growth During the","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxQOEVzcFhJN0x5b3NMd1JLRFM3Rkh5ZjYzdWtnSG0xV2Q1WjNiWG1QbjhTNV9oMTMwRHhwUk51QzgwVGdYNnF3V2RPalJtWDZqU2E2SHdPS2JJZ1lWQTFIZXVWQVZ3UjBNT096Wk1PVzNPMkhrQkJuM3RhQWhtUlNRMXZJUDZjZHVuMmZJU1ZuVF9KSnZLdDJkZXF2bGswTGJ0RWc?oc=5","date":"2024-08-26","type":"pipeline","source":"Vax-Before-Travel","summary":"Gates Grants $3,800,000 to Develop Ready-to-Use mRNA RSV Vaccine - Vax-Before-Travel","headline":"Gates Grants $3,800,000 to Develop Ready-to-Use mRNA RSV Vaccine - Vax-Before","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxOcVpjRlFDVWk4X0NlcjlfLUhPMWNEZk5zXzZlVUZFNlRjZmRqWmRsTThxVl9vSnlOZGJmNDNjOGE3a2laUEp2RTBTNnFrSkFodktyaFVITWJybm95ZUhVcUpzdm41VTFnMjNhci13Ri1NTEtibEs2RnlFMjRDVjBNMmt0SlV4WGtHTWVVMm12VkRuek41aFBFVHFkeVBqLTJrdHNpTXFSVlBwZXlVYW1rYm5hM294N3JaRmlLTzRWb2ZGRncyXzhFVjZn?oc=5","date":"2024-07-09","type":"trial","source":"BioPharma APAC","summary":"Immorna Biotherapeutics to Launch Phase 1/2 Study of Novel mRNA Therapeutic for Cancer - BioPharma APAC","headline":"Immorna Biotherapeutics to Launch Phase 1/2 Study of Novel mRNA Therapeutic for Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxNWHhPSEpiaXNtQmQxTHpkYkhzcDdndjFYeUhpREFrSV9OdExPaHVOZUJ2dTlYOE1HdDM2OWNITXVXRG11UjZlRVhqTTRqS1IyZGpnb3dPY25PQXpIMXd3cWN5WUpqUzROYzdYSHNaX3NpWmx1VEdIcmtjLVhYRmhaSWdZS1haNWVvNkhmRndOYWRuQTRlYW40Q3gyM1F5SlU2MDMtNUNySHZLQ05HSDljRDF1aUlPeFZWYm83cl9QUQ?oc=5","date":"2024-07-08","type":"regulatory","source":"Clinical Trials Arena","summary":"Immorna Biotherapeutics granted FDA IND clearance for Phase I/II JCXH-211 study - Clinical Trials Arena","headline":"Immorna Biotherapeutics granted FDA IND clearance for Phase I/II JCXH-211 study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxNdXZYSVNTX0szU2JkX293X21iYmw3cHdZWFpOMEJZX25CS215T2N2Q24wOTVoaEd5enplNkN6QTVvWWtFYS1LUnVBV1QxVHFYNkVydkxHaEtCazIyZVlwRGQteDNsazcwbEZSQXh5bG81a0FaU0pNV1hUdUdnMjJkag?oc=5","date":"2023-12-20","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech Fundraising Tracker '23: Carmot spinoff Kimia raises $55M; Lassen fuels for fibro-inflammatory mission - Fierce Biotech","headline":"Fierce Biotech Fundraising Tracker '23: Carmot spinoff Kimia raises $55M; Lassen fuels for fibro-inflammatory mission","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxNdTNPQjdRbV9QYUJKUU81bEozeElfRXlNVm10VW9CV2hQRTJqRkVra1VGSlgtZHYtWThaZTBIeXY3WHBTQkFST1djWm1Wb09zZDEtdWtVbnFzT0puSVJnUTBwQnVqTnd1VGhQemZ2TjZZVHhIWDNNTmFIN091dWdBOS1SYWJBVko2UTZod0FfSC1jTWo4OHBrb2ZfTVhQSXpDZWxIMmVuVV82OWVkSU1lenlHOEJUV1NzRjhiaWN0bXhEZ0NRME1ENHI0LWlIajczb3R3?oc=5","date":"2023-05-31","type":"trial","source":"BioPharma APAC","summary":"Immorna Initiates Phase 1 Study of JCXH-105, a Self-Replicating RNA-Based Shingles Vaccine - BioPharma APAC","headline":"Immorna Initiates Phase 1 Study of JCXH-105, a Self-Replicating RNA-Based Shingles Vaccine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7gFBVV95cUxPZlh4M2wzX0tISHFsYUFkLUZIYjVsME5IX3gxenNHWlpaczJlMFFlUXk5YjF0VHlSYzBodnlBVnNmWUd4YVJBOFRfSjEtX291STNUUUwyV3hjalJQN3QzSHpqMWNmRDg5NktXU1dBYnJSZHhqWGpTTV9nTHRnRnNGQjJLN1hHaUtKYlFxeWxjSVdST3hRblpxdHM5UkRiOW93SDJqU1ViQ1NjaFlxTXotajJFYkFiNExKVVZRbFlUMnEwYkVOck1qMi00UTU5VjI4ZS1tZjBRcTR5VjZYU0U3dkdMYVlQWDJQTEpwalN3?oc=5","date":"2022-01-31","type":"pipeline","source":"PR Newswire","summary":"Immorna Biotherapeutics Expands Its R&D Footprint in RTP, NC and Appoints Key Senior Scientific Leaders - PR Newswire","headline":"Immorna Biotherapeutics Expands Its R&D Footprint in RTP, NC and Appoints Key Senior Scientific Leaders","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}